SFXN4 Antibody, Biotin conjugated
-
中文名稱(chēng)：SFXN4兔多克隆抗體, Biotin偶聯(lián)
-
貨號(hào)：CSB-PA744046LD01HU
-
規(guī)格：￥880
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱(chēng)：Rabbit anti-Homo sapiens (Human) SFXN4 Polyclonal antibody
-
Uniprot No.：
-
基因名：SFXN4
-
別名：SFXN4; BCRM1; Sideroflexin-4; Breast cancer resistance marker 1
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human Sideroflexin-4 protein (2-110AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：Biotin
-
克隆類(lèi)型：Polyclonal
-
抗體亞型：IgG
-
純化方式：Antigen Affinity Purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA
-
Protocols：
-
儲(chǔ)存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能：Mitochondrial amino-acid transporter. Does not act as a serine transporter: not able to mediate transport of serine into mitochondria.
-
基因功能參考文獻(xiàn)：
- Our findings establish mutations in SFXN4 as a cause of mitochondriopathy and macrocytic anemia. PMID: 24119684
- we isolated a cDNA encoding a novel sideroflexin protein (SFXN4), which showed 59% identity and 71% similarity to mouse sideroflexin4. PMID: 14756423
-
相關(guān)疾病：Combined oxidative phosphorylation deficiency 18 (COXPD18)
-
亞細(xì)胞定位：Mitochondrion inner membrane; Multi-pass membrane protein.
-
蛋白家族：Sideroflexin family
-
數(shù)據(jù)庫(kù)鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
